Pacira Biosciences Inc (PCRX)

R&D Expense Growth

7.73%

Quarterly · Period ending:

PCRX logo

PCRX R&D Expense Growth

Latest reported7.73%
PCRX Quarterly R&D Growth (QoQ) (0.00% → 7.73%)
High-resolution chart · PNG

PCRX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pacira Biosciences Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
7.7337%
-25.0474%
44.2386%
-7.922%
11.2777%
6.0468%
25.089%
-6.0675%
11.5144%
-6.294%
-6.5627%
10.6566%
9.825%
-2.0851%
-9.7913%
-26.1662%
21.6478%
39.2613%
33.9955%
-7.9138%
-20.82%
3.5745%
4.6413%
7.5698%
-13.901%
-19.5085%
-2.9721%
13.6198%
23.9363%
1.4816%
-4.8533%
21.7175%
-14.8769%
43.3785%
-14.8365%
-37.553%
13.3718%
-2.5602%
74.9949%
4.1871%
-1.38%
-27.8264%
123.197%
61.4963%
-38.847%
53.5512%
-12.1808%
-15.1649%
0.2306%
7.6096%
-18.8863%
22.7507%
-17.7477%
82.0284%
-8.0238%
88.4081%
44.6677%
-50.9105%
-39.3186%
-0.8446%
24.7082%
-4.3821%
-35.7243%
24.369%
-0.991%
-38.2384%
34.9372%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.